There’s a point that many people with long-term pain reach where they know the medication on repeat prescription isn’t working well enough. Not failing dramatically, just not working enough. If you’ve been managing chronic pain for a long time and are wondering whether prescribed medical cannabis could be an option, below are the five signs that your situation might meet the clinical criteria.
Sign 1: Your Pain Has Lasted More Than Three Months Despite Treatment
Chronic pain is generally defined as pain lasting longer than three months. But duration alone isn’t what qualifies someone for medical cannabis. The more relevant question is whether conventional chronic pain treatment has been given a genuine trial and has not produced adequate relief.
If you’ve been through one or more painkillers, perhaps moved on to gabapentinoids or antidepressants used for pain, and you’re still experiencing significant daily disruption, that history is exactly what a specialist prescriber looks at. For anyone wondering whether they can get medical cannabis for chronic pain in the UK, the requirement is evidence that at least two recognised treatments have been tried. Not proof they failed completely, just that the relief wasn’t enough to restore meaningful function or quality of life.
Sign 2: The Treatments You’ve Tried Have Come With Unacceptable Side Effects
For some people, chronic pain management is less about the pain not being reduced and more about the cost of reducing it. Opioids can cause cognitive fog, constipation, and dependency. Gabapentinoids are associated with sedation and, increasingly, dependency concerns. NSAIDs taken long-term carry kidney and gastrointestinal risks.¹
If you’ve stopped a treatment not because it failed to help but because the side effects were making life as difficult as the pain itself, that counts. A specialist clinician can factor in why previous chronic pain relief treatments were discontinued, not just whether they technically worked.
Sign 3: Your Pain Is Affecting Sleep, Mental Health, or Daily Function
Chronic pain rarely exists in isolation. When pain becomes too much and starts disrupting sleep, it compounds into fatigue. Fatigue worsens pain sensitivity. Poor sleep worsens mood. Mood affects how pain is experienced. This cycle is well-documented and it’s one of the reasons single-drug approaches often fail chronic pain patients.¹
Specialist prescribers look at the full picture of how pain is affecting your life, not just a pain score. Sleep disruption, anxiety, and reductions in normal daily activity are all clinically relevant. Medical cannabis may address several of these simultaneously, which is part of its appeal in complex chronic pain presentations.
Consider someone who has been living with fibromyalgia for several years. They’ve tried two courses of medication, both of which helped initially but became less effective over time. Sleep has become a serious problem. They’re managing work but only just. This is exactly the kind of history a specialist prescriber looks at when assessing whether someone can get medical cannabis for chronic pain in the UK. It isn’t about having the worst possible symptoms. It’s about whether the treatments tried so far have genuinely been enough.
Sign 4: Your Condition Is One That Is Regularly Considered
While there is no fixed list of conditions that guarantee access, qualifying for chronic pain medical cannabis in the UK comes down to your diagnosis and your clinical history rather than a single checklist. . LeafEase’s chronic pain pathway covers the full range in detail.
These include neuropathic pain, fibromyalgia, chronic back pain, complex regional pain syndrome, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, sciatica, endometriosis-related pain, and pain associated with spinal cord injury or multiple sclerosis, among others.² If your diagnosis falls within or close to these categories, it is worth exploring whether your specific history meets the clinical threshold. The breadth of what is considered is wider than most people realise.
Sign 5: You’ve Already Tried More Than One Type of Treatment
This is the most straightforward of the five signs, and also the one most directly tied to the eligibility criteria. Medical cannabis in the UK is intended for people who have not found adequate chronic pain relief through existing treatments, not as a first-line option.
Two prior treatments is the common threshold cited by specialists. These don’t have to have been pharmaceutical. Physiotherapy, steroid injections, nerve blocks, and structured pain management programmes can all count, depending on the specific condition and clinical history.
What Happens After Your First Consultation
For many people the question isn’t just whether they qualify for chronic pain treatment through medical cannabis; it’s what actually happens if they do. Knowing the process in advance makes it easier to take the first step.
At LeafEase, once your eligibility check is complete and a consultation is booked, you meet with a GMC-registered specialist via video call. There’s no need to travel. The clinician reviews your medical history, your current symptoms, and the treatments you’ve already tried. If a prescription is appropriate, it’s sent directly to LeafEase’s licensed pharmacy partner.
Your medication is dispensed and delivered to your home, typically within 48 hours of the prescription being issued. After that, follow-up consultations are built into the process. Your clinician monitors how you’re responding, adjusts the prescription if needed, and stays involved in your care on an ongoing basis. It’s a full clinical service, not a one-off transaction.
If you recognise your situation in several of the signs above and want to find out whether you can get medical cannabis for chronic pain in the UK, you can check your eligibility to see whether a consultation is the right next step for you.
This article is for informational purposes only and does not constitute medical advice. Medical cannabis treatment requires a consultation with a qualified specialist clinician. To find out whether you may be eligible, visit leafease.co.uk.
Frequently Asked Questions
What types of chronic pain qualify for medical cannabis in the UK?
There is no fixed list, but conditions regularly considered include neuropathic pain, fibromyalgia, chronic back pain, CRPS, rheumatoid arthritis, osteoarthritis, endometriosis-related pain, sciatica, and spinal cord injury-related pain. Eligibility depends on the individual’s clinical history, not just the diagnosis.
How many treatments do I need to have tried before qualifying?
Most specialist prescribers look for evidence that at least two recognised treatments have been tried without providing adequate relief. These can be pharmaceutical or non-pharmaceutical and should be documented in your medical history.
Can I still be eligible if my pain is managed but not well enough?
Yes. The threshold is not zero relief but adequate relief. If your current pain management leaves you with significant sleep disruption, reduced daily function, or persistent distress, that can constitute insufficient relief even if the treatment is technically working.
Do I need to be referred by my GP for a medical cannabis assessment for chronic pain?
No. Self-referral is possible at private clinics. You can book an eligibility check and a consultation directly without a GP referral. Having access to your medical records or treatment history is helpful for the specialist assessment, but it is not a formal requirement.
Is medical cannabis effective for chronic pain?
Research suggests modest but meaningful improvements in pain scores for some chronic pain conditions. A 2022 meta-analysis found that non-inhaled CBMPs were associated with moderate improvements in pain relief, physical functioning, and sleep quality in chronic pain patients.³ Results vary between individuals, and this is one of the reasons specialist monitoring throughout treatment is important.
How is medical cannabis different from opioids for chronic pain?
Both act on pain pathways but through different mechanisms. Opioids bind to opioid receptors in the brain and spinal cord and carry documented risks of tolerance, dependency, and overdose. Cannabinoids act on the endocannabinoid system and have a different risk profile. For some patients, medical cannabis has allowed a reduction in opioid use, though this should always be done under clinical supervision.
What happens at a medical cannabis assessment for chronic pain?
A specialist clinician reviews your medical history, current symptoms, previous treatments, and any relevant test results. They assess whether a cannabis-based product is clinically appropriate and safe for your circumstances. If a prescription is issued, it will come with guidance on formulation, dose, and follow-up monitoring.
References
[1] National Institute for Health and Care Excellence (2021) Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. NICE Guideline NG193. Available at: https://www.nice.org.uk/guidance/ng193 [Accessed: April 2026].
[2] Home Office (2018) The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. UK Statutory Instruments 2018 No. 1055. Available at: https://www.legislation.gov.uk/uksi/2018/1055/contents/made [Accessed: April 2026].
[3] Wang, L., Hong, P.J., May, C., et al. (2021) Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ, 374, n1791. https://doi.org/10.1136/bmj.n1791
